mvAnti-MCSPxIL-15

N/A

Report date: 2025/01/26 15:09:48

Base Information

Drug NamemvAnti-MCSPxIL-15
Drug Alias NameMultivalent conjugate antibody (Valitor)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMelanoma-specific antigens inhibitorsChondroitin sulfate proteoglycans inhibitorsInterleukin-15 receptors replacement
TargetsChondroitin sulfate proteoglycansMelanoma-specific antigensInterleukin-15 receptors
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValitor Inc
China Registration ClassN/A

Develop Information

Active CompaniesValitor Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A